Search

everythinglearnresearchcommunity

for

Search:↓

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Eating the right nutrients can improve hair health, but taking extra supplements usually doesn't help unless you have a deficiency.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Different types of facial fat affect aging and treatment outcomes; more research is needed to enhance anti-aging procedures.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Changing the amount of PLC5 in Arabidopsis affects root growth and drought resistance, with less PLC5 slowing root growth and more PLC5 improving drought tolerance but hindering root hair growth.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

New acne treatments show promise as alternatives to traditional therapies.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Umbilical cord cells may help delay skin aging.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

The industry should promote pure luxury hair fibers, improve technology, and diversify products to support growers and ensure sustainable use.